Lapozan

Medicinal product

(Invented) name

Lapozan

Active substance (s)

Olanzapinas

Strength

5 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH03, Olanzapine

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2009-11-25

Date of renewal

2014-12-11

Documents

1787_1-6 Lapozan_bdt_12-11.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/1852/006/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Olanzapinas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
31774	34187	1034187	lizdinė plokštelė	N20		Receptinis	LT/1/09/1787/001	Netiekiama	-	-	No	-	-	Download
38322	51978	1051978	lizdinė plokštelė	N30		Receptinis	LT/1/09/1787/002	Netiekiama	-	-	No	-	-
38323	51979	1051979	lizdinė plokštelė	N50		Receptinis	LT/1/09/1787/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-06-05	Išregistruotas
2014-12-11	Perregistruotas
2009-11-25	Registruotas